Olliaro, Piero

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., et al. (2022) · The Lancet

Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria

Cited by 16,316

COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room

Olliaro, P., Torreele, E., & Vaillant, M. (2021) · The Lancet Microbe

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 214

What does 95% COVID-19 vaccine efficacy really mean?

Olliaro, P. (2021) · The Lancet Infectious Diseases

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 49

The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership

Lacaze, C., Kauss, T., Kiechel, J.-R., Caminiti, A., Fawaz, F., Terrassin, L., Cuart, S., Grislain, L., Navaratnam, V., Ghezzoul, B., et al. (2011) · Malaria Journal

Malaria Research and ControlPharmaceutical Quality and Counterfeiting

Cited by 24

Fixed artesunate–amodiaquine combined pre-formulation study for the treatment of malaria

Kauss, T., Fawaz, F., Guyot, M., Lagueny, A.-M., Dos Santos, I., Bonini, F., Olliaro, P., Caminiti, A., & Millet, P. (2010) · International Journal of Pharmaceutics

Pharmaceutical Quality and CounterfeitingMalaria Research and Control

Cited by 20

Transmission of malaria in relation to distribution and coverage of long-lasting insecticidal nets in central Côte d’Ivoire

Ouattara, A. F., Dagnogo, M., Constant, E. A., Koné, M., Raso, G., Tanner, M., Olliaro, P. L., Utzinger, J., & Koudou, B. G. (2014) · Malaria Journal

Malaria Research and ControlMosquito-borne diseases and control

Cited by 19